Results 191 to 200 of about 52,475 (270)

Predictive Role of Metabolic Profiling in Rivaroxaban Efficacy for Thrombus Lysis in Atrial Fibrillation. [PDF]

Int J Mol Sci
Michorowska S, Korytowska-Przybylska N, Piotrowski R, Kułakowski P, Giebułtowicz J.   +4 more
europepmc   +1 more source

Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting

, 2014
João Morais, Carlos Aguíar, Euan McLeod, Ismini Chatzitheofilou, Isabel Fonseca Santos, Sónia Pereira   +5 more
openalex   +1 more source

RIVAWAR Trial Commentary: Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction. [PDF]

JACC Adv
Abdelnabi M, Almaghraby A, Ibrahim R, Ayoub C, Arsanjani R.   +4 more
europepmc   +1 more source

Dramatic response to low-dose rivaroxaban in an Asian patient with deep vein thrombosis and pulmonary embolism [PDF]

, 2013
Junji Yamaguchi, Kunihiko Makino, Yukiko Kusunose, Shirika Higa, Takuro Takagi, Ken Suzuki, Tetsuo Lee   +6 more
openalex   +1 more source

An ADR pharmaceutical care for severe gastrointestinal bleeding of rivaroxaban in a patient with nonvalvular atrial fibrillation based on TDM and genetic testing: a case report. [PDF]

BMC Med Genomics
Huang Y, Gao H, Chen M, Lin Y, Liu H, Chen M.   +5 more
europepmc   +1 more source

Low-molecular-weight heparin followed by rivaroxaban for acute occlusive portomesenteric vein thrombosis in a cirrhotic patient treated with multiple endoscopic variceal procedures

, 2019
Xiangbo Xu, Xiaozhong Guo, Ran Wang, Le Wang, Qianqian Li, Fangfang Yi, Hongyu Li, Xingshun Qi   +7 more
openalex   +1 more source

A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising [PDF]

, 2016
Paul Burton, W. Frank Peacock
openalex   +1 more source

The Use of Estimands in the Design and Analysis of Comparative Effectiveness Trials: The PEPPER Trial. [PDF]

JB JS Open Access
Harri A, Magder LS, Franklin PD, Magaziner JS, Kernan LM, Lambourne CA, Pellegrini VD.   +6 more
europepmc   +1 more source

Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism prophylaxis: a systematic review of efficacy, safety, and cost-effectiveness. [PDF]

Front Pharmacol
Li B, Zhao L.
europepmc   +1 more source

Application Value and Safety Analysis of Warfarin, Rivaroxaban, and Dabigatran Ester in Elderly Patients With Atrial Fibrillation

Cheng Chen, Qing Tian, Chong Cheng, Xixin Ji, Mengyun Feng, Huiqun Tan, Qian Zhou   +6 more
openalex   +1 more source